Autopsy report · NCT01897077
The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy
Cause of deathDrug or device supply
“Study product manufacturing suspended due to manufacturing problems, before initiation of study intervention.”
Life of this trial
- Registered 8 months after it had already started.
- Ran for about 3 months before it stopped.
- 5 participants enrolled.
- Results were posted on the registry 5 years 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Johns Hopkins University
- Sponsor type
- University, hospital or other
- Conditions
- Peanut Allergy
- Interventions
- Peanut Dissolving Film
- Participants
- 5
- Sites
- 2
- Countries
- United States
Trials that died the same way
- Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)
“Study was stopped after careful review of product manufacturing needs and available resources. Decision reflects consideration of feasibility, enrollment challenges, and overall program goals.” - Norwegian Adenomyosis Study III: Peristalsis
“Study was suspended due to organisational difficulties.” - Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse
“Study prematurely terminated following the decision by industrial partner to withdraw from the project (product supply issue).” - Subjects With T2D or at Risk of T2D Cohort Follow-up
“The sponsor has temporarily suspended study due to operational constraints.” - A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer
“Withdrawal of Industry support for the study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.